Bellevue, WA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)CANINE CANCER RESEARCH ALLIANCE, founded in 2017, is a small nonprofit in the Animal-Related sector that reported $525K in total revenue in fiscal year 2023. Revenue surged 26% from the prior year, signaling strong growth momentum. The organization ran a surplus of $139K, a strong 27% operating margin.
CANINE CANCER ALLIANCE's MISSION IS TO END CANCER AS WE KNOW IT TODAY BY FUNDING AND ADVANCING RESEARCH FOR PREVENTION, EARLY DETECTION, AND CURES. STUDIES AND CLINICAL TRIALS SUPPORTED BY THE CCA EMPHASIZE THE DEVELOPMENT OF SAFE, EFFECTIVE, AND AFFORDABLE TREATMENTS FOR DOGS.
2023 PROGRAM FOCUSED ON CANCER IMMUNOTHERAPY RESEARCH AND EDUCATION. (1) EGFR/HER2 THERAPEUTIC CANCER VACCINE TRIAL ENROLLED OVER 100 PATIENTS ACROSS TEN CLINICS IN THE US. (YALE UNIVERSITY...
2023 PROGRAM FOCUSED ON CANCER IMMUNOTHERAPY RESEARCH AND EDUCATION. (1) EGFR/HER2 THERAPEUTIC CANCER VACCINE TRIAL ENROLLED OVER 100 PATIENTS ACROSS TEN CLINICS IN THE US. (YALE UNIVERSITY, THERAJAN) (2) GUT MICROBIOME AND IMMUNOTHERAPY TREATMENT CLINICAL TRIAL LAUNCHED. (3) FASTING AND TUMOR MICROENVIRONMENT STUDY LAUNCHED. (4) EDUCATIONAL OUTREACH ON KEY CANCER TOPICS, INCLUDING ADVANCES IN EARLY DETECTION, RISK REDUCTION, TREATMENT OPTIONS WITH VIDEO, BLOG POSTS, SOCIAL POSTS
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $524,564 | $415,845 | +0.3% |
| Expenses | $385,516 | $211,915 | +0.8% |
| Net Income | $139,048 | $203,930 | -0.3% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Mari Maeda Whitaker | Director, Officer | 40 |
Officer
Director
|
$0 | $0 | $0 |
| Tai Truong | Director | 0.5 |
Director
|
$0 | $0 | $0 |
| Sri Kumar | Director | 0.5 |
Director
|
$0 | $0 | $0 |
| Sam Earp | Director | 0.5 |
Director
|
$0 | $0 | $0 |
| Elizabeth Zuidema | Director | 0.5 |
Director
|
$0 | $0 | $0 |
| James Gimlett | Director | 1 |
Director
|
$0 | $0 | $0 |
| Jordan Katzman | Director | 10 |
Director
|
$0 | $0 | $0 |
| Norman Whitaker | Director | 4 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $524,564 | $385,516 | $516,570 | $139,048 |
| 2022 | $415,845 | $211,915 | $370,858 | $203,930 |
Compare CANINE CANCER RESEARCH ALLIANCE with other nonprofits in Washington and across the country.